Harnessing SARS‐CoV‐2‐specific CD8+ T cells to kill target tumor cells for cancer immunotherapy - Keunok Jung; Deok‐Han Ko; Jeong‐Yun Jang; Young Rong Kim; Jung Yeon Heo; Yong‐Sung Kim (Cancer Communications, 2024)